Cargando…
Global analysis of HLA-A2 restricted MAGE-A3 tumor antigen epitopes and corresponding TCRs in non-small cell lung cancer
Background: Advanced non-small cell lung cancer (NSCLC) is the most common type of lung cancer with poor prognosis. Adoptive cell therapy using engineered T-cell receptors (TCRs) targeting cancer-testis antigens, such as Melanoma-associated antigen 3 (MAGE-A3), is a potential approach for the treatm...
Autores principales: | Zhang, Bei, Ren, Zhiyao, Zhao, Jianfu, Zhu, Yue, Huang, Boya, Xiao, Chanchan, Zhang, Yan, Deng, Jieping, Mao, Lipeng, Tang, Lei, Lan, Dan, Gao, Lijuan, Zhang, Hongyi, Chen, Guobing, Luo, Oscar Junhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465222/ https://www.ncbi.nlm.nih.gov/pubmed/37649599 http://dx.doi.org/10.7150/thno.84710 |
Ejemplares similares
-
Identification of HLA-A2 restricted CD8(+) T cell epitopes in SARS-CoV-2 structural proteins
por: Deng, Jieping, et al.
Publicado: (2021) -
CD8(+) T-Cell Epitope Variations Suggest a Potential Antigen HLA-A2 Binding Deficiency for Spike Protein of SARS-CoV-2
por: Qiu, Congling, et al.
Publicado: (2022) -
Identification of Two Novel HLA-A*0201-Restricted CTL Epitopes Derived from MAGE-A4
por: Jia, Zheng-Cai, et al.
Publicado: (2010) -
Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors
por: Dillard, Pierre, et al.
Publicado: (2021) -
SARS-CoV-2 variant B.1.1.7 caused HLA-A2(+) CD8(+) T cell epitope mutations for impaired cellular immune response
por: Xiao, Chanchan, et al.
Publicado: (2022)